The role of stem cell transplantation in paediatric patients with chronic myeloid leukaemia in the era of tyrosine kinase inhibitors

被引：0
作者：
Suttorp, M.
Tauer, J. T.
von Neuhoff, N.
Nowasz, C.
Bradtke, J.
Teigler-Schlegel, A.
Thiede, C.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [41] Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors - a Retrospective Study By the EBMT Chronic Malignancies Working Party
    Radujkovic, Aleksandar
    Blok, Henric-Jan
    Nagler, Arnon
    Ayuk, Francis Ayuketang
    Finke, Juergen
    Tischer, Johanna
    Mayer, Jiri
    Yener, Koc
    Sora, Federica
    Passweg, Jakob R.
    Byrne, Jennifer
    Jindra, Pavel
    Veelken, Hendrik
    Socie, Gerard
    Maertens, Johan
    Schaap, Nicolaas
    Ganser, Arnold
    Itala-Remes, Maija
    Tholouli, Eleni
    Arat, Mutlu
    Rocha, Vanderson G.
    Ljungman, Per
    Chalandon, Yves
    Nicolaus, Kroger
    BLOOD, 2018, 132
  • [42] THERAPEUTIC CHOICES IN PATIENTS WITH PH-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA IN MEXICO IN THE ERA OF TYROSINE KINASE INHIBITORS: STEM CELL TRANSPLANTATION OR TYROSINE KINASE INHIBITORS? FIFTEEN YEARS LATER
    Robles-Nasta, Max
    Sanchez-Bonilla, Daniela
    Gallardo-Perez, Moists M.
    Hernandez-Flores, Edgar J.
    Montes-Robles, Merittzel A.
    Pastelin-Martinez, Maria De L.
    Olivares-Gazca, Juan C.
    Ruiz-Delgado, Guillermo J.
    Ruiz-Arguelles, Guillermo J.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2024, 76 (02): : 91 - 96
  • [43] Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Sasaki, Koji
    Kantarjian, Hagop M.
    O'Brien, Susan
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Wierda, William G.
    Daver, Naval
    Ferrajoli, Alessandra
    Takahashi, Koichi
    Jain, Preetesh
    Rios, Mary Beth
    Pierce, Sherry A.
    Jabbour, Elias J.
    Cortes, Jorge E.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (05) : 545 - 552
  • [44] Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors
    Sasaki, Koji
    Kantarjian, Hagop M.
    Jain, Preetesh
    Jabbour, Elias J.
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Takahashi, Koichi
    Pemmaraju, Naveen
    Daver, Naval
    Pierce, Sherry A.
    O'Brien, Susan M.
    Cortes, Jorge E.
    CANCER, 2016, 122 (02) : 238 - 248
  • [45] Stem cell allografting for chronic Myeloid leukemia in the tyrosine kinase era - forgotten but not gone
    Tang, Kenny
    Lipton, Jeffrey H.
    LEUKEMIA & LYMPHOMA, 2024, 65 (06) : 705 - 714
  • [46] Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Koji Sasaki
    Hagop M. Kantarjian
    Susan O’Brien
    Farhad Ravandi
    Marina Konopleva
    Gautam Borthakur
    Guillermo Garcia-Manero
    William G. Wierda
    Naval Daver
    Alessandra Ferrajoli
    Koichi Takahashi
    Preetesh Jain
    Mary Beth Rios
    Sherry A. Pierce
    Elias J. Jabbour
    Jorge E. Cortes
    International Journal of Hematology, 2019, 109 : 545 - 552
  • [47] Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
    Tinsley, Sara M.
    JOURNAL OF CLINICAL NURSING, 2010, 19 (9-10) : 1207 - 1218
  • [48] Outcome of allogeneic stem cell transplantation in patients with chronic myeloid leukaemia treated with second generation tyrosine kinases inhibitors after imatinib failure
    Palandri, F.
    Breccia, M.
    Iori, A. P.
    Bonifazi, F.
    Latagliata, R.
    Colaci, E.
    Torelli, G. F.
    Castagnetti, F.
    Valle, V.
    Usai, S.
    Martinelli, G.
    Dell'Agnola, C.
    Cingarlini, S.
    Rosti, G.
    Baccarani, M.
    Alimena, G.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S261 - S261
  • [49] Comparison of allogeneic stem cell transplantations in chronic myeloid leukemia before and after the era of tyrosine kinase inhibitors.
    Ozcan, Muhit
    Ozturk, Bengi
    Ozen, Mehmet
    Topcuoglu, Pervin
    Arat, Mutlu
    Arslan, Onder
    Ilhan, Osman
    Akan, Hamdi
    Beksac, Meral
    Konuk, Nahide
    Gurman, Gunhan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] Second-Generation Tyrosine Kinase Inhibitors Combined With Stem Cell Transplantation in Patients With Imatinib-Refractory Chronic Myeloid Leukemia
    Zhao, Yanmin
    Luo, Yi
    Shi, Jimin
    Cai, Zhen
    Huang, He
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2014, 347 (06) : 439 - 445
12345